Stevanato Group S.p.A STVN
NYSE STVN
$19.95 -1.03 (-4.91%)
As of: Oct 1, 2026 · 3:59 PM EDT

Stevanato Group S.p.A (STVN) Research & Development (2020 - 2026)

Updated

Stevanato Group S.p.A's Research & Development came in at $7.22 million for the quarter ended Jun 30, 2026, up 5.5% from $6.84 million a year earlier and up 5.6% from the prior quarter.

Analysis

Stevanato Group S.p.A (STVN) Research & Development (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Stevanato Group S.p.A reported Research & Development of $29.75 million, up 13.0% year-over-year; for the year ended Dec 31, 2025, it was $29.61 million, down 13.6% from the prior year.

  • Research & Development carries a five-year compound annual growth rate of 8.3% (years ended Dec 2020 to Dec 2025).
  • Going back by year, Research & Development was $34.28 million in the year ended Dec 31, 2024 (-11.2%), $38.59 million in the year ended Dec 31, 2023 (+6.5%), $36.24 million in the year ended Dec 31, 2022 (+3.4%) and $35.05 million in the year ended Dec 31, 2021 (+76.5%).
  • The five-year range for quarterly Research & Development is $5.98 million (the quarter ended Dec 31, 2024) to $11.68 million (the quarter ended Mar 31, 2024).
  • Year-over-year, Research & Development has increased for four consecutive quarters, with an average decline of 11.4% over the last eight quarters.
  • The fastest year-over-year change in Research & Development over five years came in the quarter ended Dec 31, 2021 (growth of 86.0%), and the weakest in the quarter ended Mar 31, 2025 (a decline of 46.6%).
  • Business Quant data shows STVN's Research & Development at $6.84 million (quarter ended Mar 31, 2026), $6.75 million (quarter ended Dec 31, 2025) and $8.94 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 364.00 Mn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 892.00 Mn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 412.00 Mn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 370.60 Mn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 771.00 Mn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 434.00 Mn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 554.00 Mn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 278.90 Mn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 258.00 Mn
10 Stevanato Group S.p.A 6.34 Bn 5.78 Bn 100.91 Mn 7.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.22 Mn
Mar 31, 2026 6.84 Mn
Dec 31, 2025 6.75 Mn
Sep 30, 2025 8.94 Mn
Jun 30, 2025 6.84 Mn
Mar 31, 2025 6.24 Mn
Dec 31, 2024 5.98 Mn
Sep 30, 2024 7.26 Mn
Jun 30, 2024 9.41 Mn
Mar 31, 2024 11.68 Mn
Dec 31, 2023 10.87 Mn
Sep 30, 2023 9.46 Mn
Jun 30, 2023 9.11 Mn
Mar 31, 2023 9.18 Mn
Dec 31, 2022 10.81 Mn
Sep 30, 2022 7.68 Mn
Jun 30, 2022 9.07 Mn
Mar 31, 2022 8.63 Mn
Dec 31, 2021 10.87 Mn
Sep 30, 2021 8.72 Mn
API Access

Stevanato Group S.p.A Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=STVN&period=max&api_key=YOUR_API_KEY